These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 14015321)
1. [Effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-(1,2-chromene), a selective coronary dilator agent, on circulation, respiration and metabolism]. BRETSCHNEIDER HJ; EBERLEIN HJ; KABUS HM; NELLE G; REICHMANN W Arzneimittelforschung; 1963 Apr; 13():255-68. PubMed ID: 14015321 [No Abstract] [Full Text] [Related]
2. [Studies with 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-(1,2-chromene), a new coronary vasodilator agent]. LOCHNER W; HIRCHE H Arzneimittelforschung; 1963 Apr; 13():251-5. PubMed ID: 13931172 [No Abstract] [Full Text] [Related]
3. [On the treatment of coronary heart disease with a selective, long-acting substance, 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-1,2-chromene]. MAASSEN JH Med Klin; 1963 Aug; 58():1269-70. PubMed ID: 13932010 [No Abstract] [Full Text] [Related]
4. [Biochemical pharmacological studies of the coronary dilator 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride. 1. Methods for determination of the substance and its metabolites in plasma, tissues and urine]. Klarwein M; Nitz RE Arzneimittelforschung; 1965 May; 15(5):555-8. PubMed ID: 5898299 [No Abstract] [Full Text] [Related]
5. [Protracted coronary vasodilator effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-1.2-chromene]. FIEGEL G; KELLING HW; BARGHEER R; KUKWA D Med Welt; 1963 Apr; 17():976-9. PubMed ID: 13945047 [No Abstract] [Full Text] [Related]
6. [On the biological evaluation of coronary dilator agents]. KHADZHAI IaI; CHERKASOVA IN Farmakol Toksikol; 1962; 25():573-8. PubMed ID: 14032230 [No Abstract] [Full Text] [Related]
8. [Research on the benzofurans series. I. Benzofurans possessing coronary dilator activity]. DELTOUR G; BINON F; HENAUX F; CHARLIER R Arch Int Pharmacodyn Ther; 1961 Apr; 131():84-106. PubMed ID: 13721708 [No Abstract] [Full Text] [Related]
9. [On several derivatives of 2- and 4-(beta-phenlpropionyl)-phenoxyacetic acids with presumed coronary-dilator action]. BRAMANTI G; DI PACO GF Boll Chim Farm; 1962 Oct; 101():796-808. PubMed ID: 14014910 [No Abstract] [Full Text] [Related]
10. [Spasmolytic and coronary dilator activities of some derivatives 3-ethyl chromone]. BRADEL-GAY Y; GUIROY P; BOURILLET F Therapie; 1962; 17():1211-8. PubMed ID: 14014809 [No Abstract] [Full Text] [Related]
11. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Saitoh S; Zhang C; Tune JD; Potter B; Kiyooka T; Rogers PA; Knudson JD; Dick GM; Swafford A; Chilian WM Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2614-21. PubMed ID: 17023676 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the relaxant response to N,N'-dipropyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine in porcine coronary arteries. Moritz A; Gust R; Pertz HH J Pharmacol Exp Ther; 2007 May; 321(2):699-706. PubMed ID: 17322023 [TBL] [Abstract][Full Text] [Related]
13. [5,4-d]pyrimidine on coronary circulation in the dog]. FERUGLIO FS; MIGHELI B; CAMPUS S; PANDOLFO G; ACCATINO G Minerva Med; 1960 Nov; 51():3793-6. PubMed ID: 13699197 [No Abstract] [Full Text] [Related]
14. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease. Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A Int J Cardiol; 2005 Oct; 105(1):58-66. PubMed ID: 16207546 [TBL] [Abstract][Full Text] [Related]
15. [Probable mechanism of action of coronary vasodilator drugs]. CUERVO MUNOZ C Med Esp; 1963 May; 49():508-10. PubMed ID: 14024178 [No Abstract] [Full Text] [Related]
16. Vasodilator activity of the aqueous extract of Viscum album. Tenorio FA; del Valle L; González A; Pastelín G Fitoterapia; 2005 Mar; 76(2):204-9. PubMed ID: 15752631 [TBL] [Abstract][Full Text] [Related]
17. A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts. Asanuma H; Minamino T; Sanada S; Ogita H; Kim J; Fujita M; Hirata A; Tsukamoto O; Ogai A; Node K; Hori M; Tomoike H; Kitakaze M J Mol Cell Cardiol; 2005 Oct; 39(4):605-14. PubMed ID: 16087189 [TBL] [Abstract][Full Text] [Related]
18. The changes of fractional flow reserve after intracoronary nitrate and Nicorandil injection in coronary artery ectasia. Kim W; Jeong MH; Ahn YK; Cho JG; Park JC; Kang JC Int J Cardiol; 2006 Nov; 113(2):250-1. PubMed ID: 16290224 [No Abstract] [Full Text] [Related]